Data / Form D filings / X1 Biotech Inc.
X1 Biotech Inc.: Form D filings
X1 Biotech Inc., a technology company in Needham, MA, filed 4 Form D notices with the SEC between 2025 and 2026. The latest, on June 15, 2026, reports $40,000 sold of a $2 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 935 GREAT PLAIN AVENUE #140, Needham, MA, 02492
- Phone
- (617) 834-4833
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2068848
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | New notice | $2,000,000 | $40,000 | $1,960,000 | 2 | May 20, 2026 | sec.gov |
| Dec 11, 2025 | Amendment | $300,000 | $95,000 | $205,000 | 5 | May 8, 2025 | sec.gov |
| May 21, 2025 | New notice | $200,000 | $95,000 | $105,000 | 5 | May 8, 2025 | sec.gov |
| May 21, 2025 | New notice | $2,000,000 | $100,000 | $1,900,000 | 1 | Nov 7, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Leo Kim | Director | |
| Dean Eliott | Director | |
| Joseph Arboleda-Velasquez | Director | |
| Neal Chen | Director | |
| Lawrence Kaufman | Executive Officer | |
| Michael Aceti | Executive Officer |
Other technology companies in Massachusetts that filed recently
- Betvisors, Inc. $150,000 · Oct 30, 2026
- RESOLV TECHNOLOGY, INC. $7.2 million · Oct 30, 2026
- Cala Systems, Inc. $2.6 million · Oct 27, 2026
- Boltz, PBC $97.4 million · Oct 22, 2026
- SpartanX Technologies, Inc. $5 million · Oct 22, 2026
- Govably, Inc. $375,000 · Oct 21, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in Massachusetts · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what X1 Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.